MGI Tech’s DNBSEQ-E25 and G99 platforms set record for sequencing applications at high altitude

FHS
June 7, 2024
8:59 am

MGI Tech Co., Ltd. (“MGI”), a company committed to building core tools and technologies that drive innovation in life science, recently set a new record for sequencing applications by successfully running sample testing on its cutting-edge DNBSEQ-E25 and DNBSEQ-G99 platforms on Mount Everest.

Senate Committee Wrestles With Risks and Benefits of Virus Research

Lawmakers and scientists debated the best ways to regulate high-risk government-funded virus research during a hearing of the Senate Committee on Homeland Security and Governmental

July 12, 2024

A catalyst for quality: FDA’s Voluntary Improvement Program saves time, improves process and enhances patient outcomes

The US Food and Drug Administration (FDA) recently announced its support of the Case for Quality Voluntary Improvement Program (VIP) through a final Guidance published in

November 13, 2023

As England’s virus hospitalisations surge flu vaccines evolve – Pharmaceutical Technology

Share this article Moderna is leading the mRNA influenza vaccine race with its mRNA-1010 candidate. Image credit: Shutterstock/Cryptographer. England’s National Health Service (NHS) has revealed

February 2, 2024

Supercharge Your Portfolio with Future Health Stocks!

Join us for Profitable Insights & Expert Tips!

With expert analysis, comprehensive market coverage, and actionable insights, our newsletter equips you with the knowledge & tools necessary to make informed decisions & maximize your potential returns in the dynamic world of future health stocks.